LABEX OF SCANDINAVIA
Clas Runnberg is an experienced executive with a robust background in board leadership and management within the life sciences and investment sectors. Currently serving as Chairman of the Board at LABEX Group since June 2019 and Owner of Intravenator AB since May 2010, Runnberg also holds the position of Senior Advisor at Valedo, a Swedish private equity group. Notable past roles include Board Member at Monivent AB and Chairman of the Board at P.U.L.S. AB, alongside significant contributions at HemoCue AB as Acting CEO and other managerial positions. Runnberg's educational background includes a Diploma in Marketing Economics from Lunds universitet and studies at Ängelholms gymnasium.
This person is not in any teams
This person is not in any offices
LABEX OF SCANDINAVIA
During the years we have evolved and today we have a clear business strategy for the Healthcare (IVD/MD) and Life Science market. As a distributor we supply solutions that provide value in terms of quality, efficiency, and safety within two separate business areas. We offer a wide range of innovative products and services to our customers within Healthcare but we also have a series of carefully selected niche products for customers within the Life Science sector Since the start in 1973, we are a successful supplier of diagnostics and instruments to laboratories in hospitals, universities and pharmaceutical industry. 1986, we started producing diagnostic reagents. ISO 9001:2015 14001:2015 certified, all products are CE-marked. Head office SVENSKA LABEX, Helsingborg, Sweden Branch offices LABEX ApS, Copenhagen, Denmark NORSK LABEX A/S, Oslo, Norway